Medesis Pharma SA (ALMDP) — Net Asset Momentum
Medesis Pharma SA (ALMDP) recorded a net asset momentum of -325.4% as of December 2023, with net assets of €-4.50 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See ALMDP total equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Medesis Pharma SA Net Asset Momentum (2018–2023)
This chart tracks Medesis Pharma SA's year-over-year net asset growth across 6 annual reporting periods from 2018 to 2023. The most recent momentum reading is -325.4%, with net assets of €-4.50 Million EUR as of December 2023. Check tangible net worth ratio of Medesis Pharma SA to evaluate the tangible quality of the company's equity base.
Annual Net Asset History for Medesis Pharma SA (2018–2023)
The table below shows the complete annual net asset history for Medesis Pharma SA from 2018 to 2023, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Medesis Pharma SA market cap and net worth.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2023 | €-4.50 Million | €1.93 Million | €6.43 Million | ▼ -325.4% |
| 2022 | €-1.06 Million | €1.92 Million | €2.97 Million | ▼ -164.3% |
| 2021 | €1.65 Million | €4.33 Million | €2.68 Million | ▲ +179.0% |
| 2020 | €-2.08 Million | €837.91K | €2.92 Million | ▲ +13.9% |
| 2019 | €-2.42 Million | €714.00K | €3.13 Million | ▼ -176.0% |
| 2018 | €-876.00K | €1.62 Million | €2.50 Million | — |